OTTAWA (Reuters) -Canada on Friday authorized the use of Pfizer Inc's COVID-19 vaccine for children aged 5 to 11, paving the way for the inoculation of basic college-age children throughout the country.
The shot is the primary to be made available for young children in Canada. officers had made clear for weeks that the decision would be favorable, noting that incidences of COVID-19 are maximum in those under 12.
"After an intensive and independent scientific evaluate of the evidence, the branch has decided that the merits of this vaccine for infants between five and eleven years of age outweigh the hazards," health Canada stated in a press release.
separately, Pfizer Canada noted in an announcement it will begin sending shipments imminently.
The vaccine may be given in two doses of 10 micrograms, three weeks apart. adult doses contain 30 micrograms.
top Minister Justin Trudeau stated final month that Ottawa had signed a take care of Pfizer to promptly acquire 2.9 million doses of the vaccine once it become accepted.
health Canada referred to clinical trials confirmed the vaccine turned into ninety.7% helpful at fighting COVID-19 in these aged between 5 to eleven and no serious side results had been recognized.
The U.S. food and Drug Administration https://www.reuters.com/world/us/us-fda-expected-authorize-first-covid-19-vaccine-young-babies-friday-nyt-2021-10-29 authorized use of the vaccine for those aged 5 to 11 on Oct. 29.
Canadian officers have been expected to provide more details at a news convention at 10 a.m. (1500 GMT) on Friday.
(Reporting by using Julie Gordon and David Ljunggren in Ottawa; editing with the aid of Barbara Lewis and Jonathan Oatis)
0 Comments